Detailed Information on Publication Record
2016
Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report
SMETANA, Jan, Petr KUGLÍK, Henrieta GREŠLIKOVÁ, Renata KUPSKÁ, Pavel NĚMEC et. al.Basic information
Original name
Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report
Authors
SMETANA, Jan (203 Czech Republic, guarantor, belonging to the institution), Petr KUGLÍK (203 Czech Republic, belonging to the institution), Henrieta GREŠLIKOVÁ (703 Slovakia, belonging to the institution), Renata KUPSKÁ (203 Czech Republic, belonging to the institution), Pavel NĚMEC (203 Czech Republic, belonging to the institution), Aneta MIKULÁŠOVÁ (203 Czech Republic, belonging to the institution), Iveta VALÁŠKOVÁ (203 Czech Republic), Jan OPPELT (203 Czech Republic, belonging to the institution), Martina ALMÁŠI (203 Czech Republic, belonging to the institution), Marta KREJČÍ (203 Czech Republic), Zdeněk ADAM (203 Czech Republic), Luděk POUR (203 Czech Republic) and Roman HÁJEK (203 Czech Republic, belonging to the institution)
Edition
International Journal of Clinical and Experimental Pathology, USA, e-Century Publishing Corporation, Madiso, 2016, 1936-2625
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.706
RIV identification code
RIV/00216224:14310/16:00088866
Organization unit
Faculty of Science
UT WoS
000371354200006
Keywords in English
Multiple myeloma; extramedullary relapse; clonal evolution; genetic changes; ploidy switch; TP53 mutations
Tags
International impact, Reviewed
Změněno: 26/4/2017 22:00, Ing. Andrea Mikešková
Abstract
V originále
Extramedullary relapse (EM) is an aggressive form of the disease with a dismal outcome. We present cytogenetic findings of a 52-year-old female with MM, which progressed rapidly into plasmocellular leukemia and extramedullary subcutaneous tumor in the head. At the time of diagnosis, G-banding showed hypotriploid karyotype (63-64 chromosomes) and using cIg-FISH we found translocation t(4;14)(p16;q32) and gain(1)(q21). At the time of disease progression, the same chromosomal abnormalities were present in the bone marrow, peripheral blood and the EM lesion: del(13)(q14), del(17)(p13), t(4;14)(p16;q32) and gain(1)(q21). Before progression, array-CGH showed, hyperdiploid karyotype with trisomies of chromosomes 2, 3, 7, 8, 9, 11, 17, 18, 19 and 20, while after progression non-hyperdiploid karyotype was detected with additional structural deletions in 1p, 2p, 4q, 11p, 12p, 13, 14q, 17p, 22q and homozygous deletion in 1p32.3. In addition, deep resequencing of TP53 showed presence of 2 known mutations in exon 6(c.632C>T) and exon 7(c.700T>C). In summary, EM relapse of this patient was connected to a change of the entire genome profile. Extramedullary lesion most probably originated by an expansion of one clone of tumor plasma cells from the bone marrow, which was confirmed by identical genomic profile of both tested samples. Thus, change of ploidy status should be considered as potential hallmark of adverse course of the disease.
Links
EE2.3.20.0183, research and development project |
| |
NT13492, research and development project |
|